Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. - Wikidata - wikimedia - TriplyDB

Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation.

Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation.

http://www.wikidata.org/entity/Q34350918

about

Targeting Reactive Carbonyl Species with Natural Sequestering Agents Protein lipoxidation: Detection strategies and challenges Role of methylglyoxal in Alzheimer's disease Protein Oxidation in Aging: Does It Play a Role in Aging Progression?Methylglyoxal: An Emerging Signaling Molecule in Plant Abiotic Stress Responses and Tolerance Nonenzymatic Reactions above Phospholipid Surfaces of Biological Membranes: Reactivity of Phospholipids and Their Oxidation Derivatives Consequences of metabolic and oxidative modifications of cartilage tissue Biomonitoring Human Albumin Adducts: The Past, the Present, and the Future Extending the spectrum of α-dicarbonyl compounds in vivo.Impaired Chaperone Activity of Human Heat Shock Protein Hsp27 Site-Specifically Modified with Argpyrimidine.Global Proteomic Analysis of Advanced Glycation End Products in the Arabidopsis Proteome Provides Evidence for Age-related Glycation Hotspots.Early AMD-like defects in the RPE and retinal degeneration in aged mice with RPE-specific deletion of Atg5 or Atg7 Dietary Sugars and Endogenous Formation of Advanced Glycation Endproducts: Emerging Mechanisms of Disease.The relationship between circulating irisin levels and tissues AGE accumulation in type 2 diabetes patients.Neuroprotective effect of carnosine against salsolinol-induced Parkinson's disease Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans.Dicarbonyl stress and atherosclerosis: is it all RAGE?Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study.Oxidative stress and its significant roles in neurodegenerative diseases and cancer.tRNA modifications regulate translation during cellular stress.Carbohydrates and endothelial function: is a low-carbohydrate diet or a low-glycemic index diet favourable for vascular health?Novel advances in shotgun lipidomics for biology and medicine.Glycation of bovine serum albumin by ascorbate in vitro: Possible contribution of the ascorbyl radical?Skin Autofluorescence in Systemic Sclerosis Is Related to the Disease and Vascular Damage: A Cross-Sectional Analytic Study of Comparative Groups Hsp31 Is a Stress Response Chaperone That Intervenes in the Protein Misfolding Process Uremic Toxicity of Advanced Glycation End Products in CKD.Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells.Improving protein content and quality by over-expressing artificially synthetic fusion proteins with high lysine and threonine constituent in rice plants.Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.Subcutaneous liraglutide ameliorates methylglyoxal-induced Alzheimer-like tau pathology and cognitive impairment by modulating tau hyperphosphorylation and glycogen synthase kinase-3β Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis.Baking, ageing, diabetes: a short history of the Maillard reaction.Coffee components and cardiovascular risk: beneficial and detrimental effects.Coumarin derivatives: an updated patent review (2012-2014).Prevention of protein glycation by natural compounds.Gel-free proteomic methodologies to study reversible cysteine oxidation and irreversible protein carbonyl formation.Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies.Effect of diet-derived advanced glycation end products on inflammation.Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.

P2860

Q26765482-B0A1DA0E-8176-4982-984D-3D8BE625B66B Q26824737-B26780B7-3000-4013-9B31-BB17A3BC743C Q27004644-8F8E4D07-3DC0-478D-8FA4-B33265906663 Q27021668-E2DC4069-3EC3-4595-BEE9-ADBD7FE525AE Q28075320-163B3717-3E78-4BBC-B69F-00C45B3AFC38 Q28080632-B87ADC51-FE4A-40EA-8EE8-4E0293B8DE0B Q28085716-9C99BA51-022B-4438-BE7F-42F273944C1E Q28468289-C5C9A862-D316-4C4D-9BC3-29FFB17C8C30 Q30317115-D5F682C3-B1F8-4C62-8CC3-5CC8E7F9B757 Q30390809-BE5C2552-9486-4FCF-A1B6-A8D813A3A320 Q30403010-D1F4C967-20FE-48E8-AAB9-600D40E70306 Q33585812-EDCBB0AD-7469-45B7-9351-B36396634687 Q33616876-A91CE9F8-3F5E-4754-8110-0805438D2055 Q33775921-9B6D9F04-1DB4-4623-BF4A-88C7D23AC07C Q33846809-79499771-9176-4279-A169-9273D7E32655 Q33862472-9ACD8FF7-2634-44FA-A894-A802792FD950 Q34393408-E42CD0FF-D512-4666-B7A4-151A78DB62F5 Q34706565-A416DE73-8657-4CF6-ADDB-C5BB66D10A42 Q35016411-F65610B2-E1A9-4D40-AF1B-0233C80671FF Q35490491-F1F70C12-1319-47A8-8D57-204EBC21F33B Q35565420-4C1A8F46-C225-4156-B46C-B8293250C56C Q35878177-42C309D3-7A3B-4CF9-98C8-1029C4EF1073 Q35909483-0EAFFE25-7BA4-4C9F-8C05-8D0AF0000705 Q35924733-101B524A-E624-4002-86B8-B5CA7E24510D Q36139835-C22431F4-B822-4D60-BBE3-6BEF37499D52 Q36514906-504CDDDB-A8CC-4CC5-90E2-B22362D07A3B Q37223268-7137E6D9-5105-444C-B3F1-64BE8FE3DEFD Q37291193-89D915C1-57CB-42A4-A06D-6617E51B959F Q37382495-A36ADA64-5850-430E-A494-704A084867AE Q37685201-47DE2390-00BE-4BE3-9E02-CA51F03E10D8 Q37690997-CE3F19E0-628C-4049-B84C-86039287549E Q38232036-4D2853BB-95B1-4750-ACF2-F40ECBCA4910 Q38232207-44C52850-0DBC-4B64-9923-348309E08707 Q38261279-AFE5A61A-935A-47C9-B8AE-F21F232C4194 Q38358965-A4F58514-56AF-44A4-B451-610993887410 Q38381578-B54681A9-4BD0-445E-B1DB-DB6101D98D05 Q38460480-3140E1C2-1A68-4E47-8DCB-69BC9870740C Q38588208-F3461A42-1EA6-440E-8DD7-CDD5418D776E Q38661408-5DF773EF-A77A-4DA8-AEC7-99568C9B355C Q38686477-E842B260-B342-4671-9E15-F6F7770E4D06

P2860

Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation.

http://www.wikidata.org/entity/Q34350918

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Advanced glycoxidation and lip ...... their mechanisms of formation.

@ast

Advanced glycoxidation and lip ...... their mechanisms of formation.

@en

Advanced glycoxidation and lipoxidation end products

@nl

type

label

Advanced glycoxidation and lip ...... their mechanisms of formation.

@ast

Advanced glycoxidation and lip ...... their mechanisms of formation.

@en

Advanced glycoxidation and lipoxidation end products

@nl

prefLabel

Advanced glycoxidation and lip ...... their mechanisms of formation.

@ast

Advanced glycoxidation and lip ...... their mechanisms of formation.

@en

Advanced glycoxidation and lipoxidation end products

@nl

P1433

Q34350918-EDCA1BFE-635D-46B8-A44D-D9DB8224099B

P1476

Q34350918-063BE08F-653F-46FF-B246-45A0C1D6C370

P2093

Q34350918-0C6BFEBB-3738-4629-AA62-7C41D8A02642

Q34350918-450B90A3-A471-46A4-9207-B9573ADDFBE7

Q34350918-49962656-EBFD-4AE0-A686-DA469A770657

P2860

Q34350918-025F9AC2-1532-4DE8-B996-5875DD98D81C

Q34350918-0281A82B-D2B5-4A4A-95E0-3ADD0D8D141B

Q34350918-042E17A6-5B8F-4185-827A-13DE6BB96966

Q34350918-04BE1D89-029B-4F46-8759-E2121F725A70

Q34350918-05B1E300-AA34-4C2E-9250-0D1D2B396B76

Q34350918-075007A3-DD02-466C-9B0E-4F699C251549

Q34350918-08EFA141-FD9F-4D2D-AB35-EA6B11474F72

Q34350918-08FE82F9-68DF-442D-8789-6B2B375C56D1

Q34350918-09D588D3-72EA-4544-BEDB-81DF129E9F0D

Q34350918-0CF4BD03-CB97-45F1-81FB-FB24B10B88DF

P304

Q34350918-074F3A0E-A25A-4714-BA11-85199912CEA8

P31

Q34350918-B14DBA16-7A8C-41AD-8EE7-2B084B0492D7

P356

Q34350918-55516720-9C0A-40D4-B775-0893136BF238

P478

Q34350918-0503A95C-0291-4C72-99D0-B45BDE1149DF

P50

Q34350918-ABDE6A83-D1D1-4AFD-AB54-122AA3BDBBF3

Q34350918-D98962F4-545E-483E-BF2D-1CB7E1753D91

Q34350918-F1039478-CFAA-477F-A1DE-5182FE93F6BA

P577

Q34350918-273A8418-BD20-46EA-A771-CBF057B88B4B

P5875

Q34350918-897DDB0A-D972-45DD-96AD-1DB02574CAC1

P698

Q34350918-02D37ED8-6C16-42F6-88BC-11DA668157C0

P356

10715762.2013.815348

P1433

Free Radical Research

P1476

Advanced glycoxidation and lip ...... their mechanisms of formation

@en

P2093

A Cipak

http://www.w3.org/2001/XMLSchema#string

D De Maddis

http://www.w3.org/2001/XMLSchema#string

N Zarkovic

http://www.w3.org/2001/XMLSchema#string

P2860

Sucrose, high-fructose corn syrup, and fructose, their metabolism and potential health effects: what do we really know?

Identification of glucose-derived cross-linking sites in ribonuclease A

Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily

Formation pathways for lysine-arginine cross-links derived from hexoses and pentoses by Maillard processes: unraveling the structure of a pentosidine precursor

Identification and quantification of major maillard cross-links in human serum albumin and lens protein. Evidence for glucosepane as the dominant compound

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

Production of 1,2-propanediol from glycerol in Saccharomyces cerevisiae

A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress

Carbohydrate carbonyl mobility--the key process in the formation of alpha-dicarbonyl intermediates

Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes

P304

3-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10715762.2013.815348

http://www.w3.org/2001/XMLSchema#string

P478

47 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Giancarlo Aldini

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

239943457

http://www.w3.org/2001/XMLSchema#string

P698

23767955

http://www.w3.org/2001/XMLSchema#string